Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials: Guidance for Sponsors, Clinical Investigators, and IRBs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 1, 2008
July 21, 2021
3358ed6a-403d-4aaa-b66c-941d2d2630ab
Related Documents
Role of HIV Drug Resistance Testing in Antiretroviral Drug Development
Guidance DocumentOctober 31, 2007Center for Drug Evaluation and Research
180-Day Exclusivity When Multiple ANDAs Are Submitted on the Same Day
Guidance DocumentJuly 1, 2003Center for Drug Evaluation and Research
Frequently Asked Questions - IRB Registration: Guidance for Institutional Review Boards (IRBs)
Guidance DocumentJuly 9, 2009Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.